GTG 7.50% 4.3¢ genetic technologies limited

Ann: New Product Announcement, page-106

  1. 824 Posts.
    lightbulb Created with Sketch. 44
    Genetic Technologies Ltd (GTG) reported that following substantial scientific research and genetic product development, two new ground-breaking cancer risk assessment tests have now been completed and validated. The tests are branded as ‘GeneType for Colorectal Cancer’ and ‘GeneType for Breast Cancer’

    http://crweworld.com/article/news-provided-by-globenewswire/1090918/genetic-technologies-limited-asx-code-gtg-nasdaq-ticker-gene-announces-successful-completion-of-two-new-ground-breaking-genetic-risk-tests-for-colorectal-cancer-and-for-breast-cancer-
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
4.3¢
Change
0.003(7.50%)
Mkt cap ! $6.252M
Open High Low Value Volume
4.0¢ 4.3¢ 4.0¢ $4.298K 100.1K

Buyers (Bids)

No. Vol. Price($)
1 6530 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 49918 1
View Market Depth
Last trade - 15.33pm 11/09/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.